Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Humanizing the Collision Claims Experience in the Digital Age
Today’s customers have high expectations.
Mitchell
News Release
Arizona Industrial Commission Proposes Changes to Pharmacy Fee Schedule
Of particular interest are the proposed changes to the pharmacy reimbursement sections.
Mitchell
News Release
Texas Joins Ranks of States with Opioid Limits
The Texas legislature passed HB 2174, implementing several policy changes related to the prescribing of opioids, including new prescribing limits f
Mitchell
News Release
Property & Casualty in the Age of Humane Automation
As Mitchell President and CEO Alex Sun writes in Carrier Management, “Humane automation is the notion that as companies add artificial intelligence
Workers' Comp
News Release
The Heart of Case Management Awards
The Heart of Case Management Awards recognizes Genex case managers who have gone beyond traditional duties to improve the lives of injured employee
Workers' Comp
Blog
Top Therapeutic Classes by Age of Claim in 2018
In this video blog we discuss the types of medications utilized by